The Intercept is a left-wing, online newsroom that has been in business for a decade. It started in 2014 when its founders broke the story of Edward Snowden’s leaked government surveillance files, ...
Last week, a New York federal judge ruled a key copyright violation claim by The Intercept against OpenAI would move ahead in court. The ruling is the latest in a series of major legal decisions ...
The stock is exploding following an announcement that it's on track to be acquired. Alfasigma is poised to buy Intercept at a price of $19 per share. The deal stands a very good chance of being ...
Following a meeting with the FDA’s Gastrointestinal Drug Advisory Committee Friday, the future of Intercept’s rare liver disease drug Ocaliva is under serious threat. Looking to assess whether Ocaliva ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback